Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Chan, W. C.
Right arrow Articles by Schentag, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chan, W. C.
Right arrow Articles by Schentag, J. J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1999) 43, 55-60
© 1999 The British Society for Antimicrobial Chemotherapy

Markedly different rates and resistance profiles exhibited by seven commonly used and newer ß-lactams on the selection of resistant variants of Enterobacter cloacae

Wai C. Chana, Ronald C. Lia,*, Julia M. Lingb, Augustine F. Chengb and Jerome J. Schentagc

a Department of Pharmacy, The Chinese University of Hong Kong, Shatin, Hong Kong; b Department of Microbiology, The Chinese University of Hong Kong, Shatin, Hong Kong; c Department of Pharmaceutics, School of Pharmacy, State University of New York at Buffalo, NY, USA

Seven ß-lactam antibiotics (cefepime, cefoperazone, ceftazidime, ceftriaxone, cefamandole, imipenem and meropenem) were tested for their potential to select resistance in standard and clinical strains of Enterobacter cloacae (n = 9). The strains were subcultured daily with the test antibiotics at doubling concentrations starting at 0.125 x MIC. Development of resistance throughout the passages was detected by a disc diffusion test. Ceftazidime, ceftriaxone and cefamandole selected resistance at a faster rate than cefoperazone, cefepime and meropenem. Imipenem did not select resistance in the nine strains tested and was the only antibiotic that eradicated all the strains during selection. The resistance patterns of strains selected by meropenem, cefepime and the other cephalosporins were markedly different, although cross-resistance to the early generation cephalosporins was common. The resistance phenotypes of most strains remained stable upon serial passages in antibiotic-free medium. The findings of this study highlight the importance of the choice of antibiotic for therapy not only on the basis of its antibacterial activity, but also on its potential to select resistance to itself and other antibiotics.

* Corresponding author. Tel: +852-2609-7983; Fax: 852-2603-5295; E-mail: ronli{at}cuhk.edu.hk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Arch Intern MedHome page
S. E. Cosgrove, K. S. Kaye, G. M. Eliopoulous, and Y. Carmeli
Health and Economic Outcomes of the Emergence of Third-Generation Cephalosporin Resistance in Enterobacter Species
Arch Intern Med, January 28, 2002; 162(2): 185 - 190.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
P. Ball, F. Baquero, O. Cars, T. File, J. Garau, K. Klugman, D. E. Low, E. Rubinstein, R. Wise, and T. Consensus Group on Resistance and Prescribing in R
Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence
J. Antimicrob. Chemother., January 1, 2002; 49(1): 31 - 40.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
J. Ruiz, A. Jurado, E. Garcia-Mendez, F. Marco, L. Aguilar, M. T. Jimenez de Anta, and J. Vila
Frequency of selection of fluoroquinolone-resistant mutants of Neisseria gonorrhoeae exposed to gemifloxacin and four other quinolones
J. Antimicrob. Chemother., October 1, 2001; 48(4): 545 - 548.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
C. E. Thorburn and D. I. Edwards
The effect of pharmacokinetics on the bactericidal activity of ciprofloxacin and sparfloxacin against Streptococcus pneumoniae and the emergence of resistance
J. Antimicrob. Chemother., July 1, 2001; 48(1): 15 - 22.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
L. Drago, E. De Vecchi, B. Mombelli, L. Nicola, M. Valli, and M. R. Gismondo
Activity of levofloxacin and ciprofloxacin against urinary pathogens
J. Antimicrob. Chemother., July 1, 2001; 48(1): 37 - 45.
[Abstract] [Full Text] [PDF]


Home page
J Antimicrob ChemotherHome page
R. N. Jones
Conventional dogma applied to quinolones? Time for a change
J. Antimicrob. Chemother., June 1, 2001; 47(6): 893 - 893.
[Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
D. Xuan, M. Zhong, H. Mattoes, K. Q. Bui, J. McNabb, D. P. Nicolau, R. Quintiliani, and C. H. Nightingale
Streptococcus pneumoniae Response to Repeated Moxifloxacin or Levofloxacin Exposure in a Rabbit Tissue Cage Model
Antimicrob. Agents Chemother., March 1, 2001; 45(3): 794 - 799.
[Abstract] [Full Text]


Home page
J Antimicrob ChemotherHome page
M. D. Cubbon and R. G. Masterton
New quinolones--a fresh answer to the pneumococcus
J. Antimicrob. Chemother., December 1, 2000; 46(6): 869 - 872.
[Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.